Non-invasive, transdermal, continuous glucose monitoring (CGM) system utilizing a patented skin permeation platform technology that will enable both needle-free drug delivery and analyte extraction
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of Echo Therapeutics (NASDAQ: ECTE) plus 4808 other startups.